Pharma Commercial Mock
← All views·CI feed·API docs
AASCO
Meeting Library
ASCO Annual Meeting 2026 · Chicago, IL
8 shown of 6,658 total abstracts
  1. Abstract 66192026-06-04 · 16:45 CT · Hall B1
    Quality of life outcomes with Opdivo in patients with RCC
    S. Antonia, M.C. Garassino, A. Spira, et al. · National Cancer Center Japan
    Clinical Science SymposiumGenitourinary Cancer—Kidney/Bladder📄🖼️
  2. Abstract 61192026-06-01 · 15:00 CT · Hall B1
    Real-world effectiveness of Opdivo vs standard of care in RCC
    N. Rizvi, H. Rugo, S. Modi, et al. · MD Anderson Cancer Center
    Clinical Science SymposiumGenitourinary Cancer—Kidney/Bladder📄🖼️
  3. Abstract 66932026-06-03 · 21:00 CT · E450
    Real-world effectiveness of Keytruda vs standard of care in RCC
    T. Mok, C. Saura, G. Curigliano · Dana-Farber Cancer Institute
    Clinical Science SymposiumGenitourinary Cancer—Kidney/Bladder📄🖼️
  4. Abstract 61952026-06-05 · 14:15 CT · S406
    CheckMate-229: Opdivo (nivolumab) adjuvant in RCC
    S. Tolaney, L. Paz-Ares · Johns Hopkins Kimmel Cancer Center
    Clinical Science SymposiumGenitourinary Cancer—Kidney/Bladder📄🖼️
  5. Abstract 60502026-06-05 · 18:45 CT · S100A
    KEYNOTE-154: Keytruda (pembrolizumab) 1L in RCC
    F. Andre, S. Tolaney, R. Herbst, et al. · Karolinska Institute
    Clinical Science SymposiumGenitourinary Cancer—Kidney/Bladder📄🖼️
  6. Abstract 65842026-06-03 · 14:15 CT · Arie Crown Theater
    Long-term follow-up of Keytruda neoadjuvant for RCC: KEYNOTE-279
    J. Cortes, A. Spira, J. Brahmer · National Cancer Center Japan
    Clinical Science SymposiumGenitourinary Cancer—Kidney/Bladder📄🖼️
  7. Abstract 68392026-06-02 · 14:30 CT · S100A
    Long-term follow-up of Opdivo 1L for RCC: CheckMate-806
    J. Cortes, M. Krop, J. Brahmer · Memorial Sloan Kettering Cancer Center
    Clinical Science SymposiumGenitourinary Cancer—Kidney/Bladder📄🖼️
  8. Abstract 64542026-06-02 · 14:45 CT · Arie Crown Theater
    Opdivo plus chemotherapy in previously untreated RCC: updated analysis from CheckMate-903
    S. Antonia, M.C. Garassino, S. Tolaney, et al. · Cleveland Clinic
    Clinical Science SymposiumGenitourinary Cancer—Kidney/Bladder📄🖼️
© 2026 American Society of Clinical Oncology · Citations follow JCO supplement format:J Clin Oncol 44, 2026 (suppl 17; abstr XXXX). Demo mock.